Processa Pharmaceuticals, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 14/08/2026 | Mar 2026Filed 14/08/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 14/08/2026 | Mar 2025Filed 14/08/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 06/11/2025 | Mar 2024Filed 06/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$3.3 | −$3.4 | −$3.4 | −$3.9 | −$2.8 | −$3.4 | −$3 | −$2.7 | |
| −$1.19 | −$1.29 | −$0.07 | −$6.26 | −$7.58 | −$1.03 | −$1.01 | −$1.11 | |
| 2.8 | 2.6 | 48 | — | — | 3.3 | 3 | 2.5 |
Trend